Log in


   850 Ridge Avenue Pittsburgh, PA  15212


      Phone:  412.321.5030   

      Fax:      412.321.5323

Log in

Join | Renew 


The Greater Pittsburgh Diabetes Club (GPDC) is a group of multidisciplinary clinicians who have a special interest in diabetes. We provide a venue for non-biased specialty level educational programs, networking, and social interaction.

Members of the GPDC are residents of the Greater Pittsburgh / Southwestern Pennsylvania area who are actively engaged in diabetes research, the teaching of diabetes care, and/or the practice of endocrinology.  Membership to the GPDC is open to Adult and Pediatric endocrinologists (MDs and DOs), NPs, PAs who specialize in endocrine and/or diabetes care; Pharmacists, Dietitians, Nurses who specialize in endocrine and/or diabetes care; and other clinical health professionals with a special interest in diabetes.  In addition, fellows in the field of endocrinology and metabolism are members, free from dues.

The Club hosts two dinner programs per year with  CME and CEU credit offerings.  A deep discount (complimentary at times) to attend each program is offered to members.  The meetings also serve to network with colleagues and friends in a social setting.  Your input and participation are encouraged.

We welcome new members!  Dues are $25/year. Anyone interested in joining the Greater Pittsburgh Diabetes Club or attending a program should contact Nadine Popovich at 412-321-5030 or email  


November 10, 2021 Program

Over 30 in-person attendees and 29 Virtual attendees participated in the GPDC inaugural hybrid meeting, featuring Anne Peters, MD.

In person guests enjoyed a lively vendor showcase, featuring 11 exhibitors.  The Society would like to thank the following who participated in and supported the program:  Abbott, AstraZeneca, Bayer, Boehringer-Ingelheim, Corcept Therapeutics, NASH kNOWledge, Novo Nordisk, Sanofi, Tandem Diabetes Care, Xeris Pharmaceuticals, and Zealand Pharmaceuticals.

Anne L. Peters, MD, Professor of Clinical Medicine, Keck School of Medicine of USC; Director, USC Clinical Diabetes Programs presented, When to Use SGLT-2 Inhibitors and GLP-1 RA’s in the Management of Type 1 Diabetes.   Dr. Peters’  research has focused on testing new approaches for diagnosing and treating diabetes and developing systems of care to improve outcomes in diabetic populations.  She has published over 200 articles, reviews, and abstracts and three books on diabetes.

Dr. Peters  has been an investigator on over 40 research studies and has spoken at over 400 programs throughout the US as well as internationally.  She has served on many committees for the ADA and other organizations. Currently she is the chair of the Endocrine Society Committee on Diabetes Devices and is on the EASD/ADA Technology Safety Committee.

Attendees enjoying the Vendor Showcase

In-Person attendees participating in the Q&A session. 

Powered by Wild Apricot Membership Software